ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 643813 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 643813; 2) Community: the network communities that were significantly associated with the response to NSC 643813; 3) Molecule: the relationships between components within communities and NSC 643813; 4) MDR: the compounds that were significantly associated with the NSC 643813.

NSC Compound Enrichment Correlation
NSC 106969 CENTAUREIDIN 0.00888636978630788 0.55189929
NSC 1390 Allopurinol 0.00888636978630788 -0.1094387
NSC 374979 Null 0.00888636978630788 0.46372558
NSC 629749 .beta.-Lapachone 0.00888636978630788 0.48631732
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.00888636978630788 0.20888481
NSC 638294 Null 0.0102077332082016 0.33918136
NSC 651590 ANTINEOPLASTIC-651590 0.0102077332082017 0.19546178
NSC 682436 Naphth[2,3-d]oxazol-9(4H)-one, 4-[(2-aminocyclohexyl) imino]-2-methyl-, acetate 0.0102077332082017 0.49584327
NSC 100071 component of Halotex 0.0102962192514438 0.076071402
NSC 1393 4-APP 0.0102962192514438 -0.14337122
Total:78  Current:19    [First] [Prev] [Next] [Last]